<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-YGBF1TMN</identifier><date>2025</date><creator>Andlovic, Aljoša</creator><creator>Dejanović, Katja</creator><creator>Škrbinc, Breda</creator><relation>documents/doc/Y/URN_NBN_SI_doc-YGBF1TMN_001.pdf</relation><relation>documents/doc/Y/URN_NBN_SI_doc-YGBF1TMN_001.txt</relation><format format_type="issue">1</format><format format_type="volume">29</format><format format_type="type">article</format><format format_type="extent">str. 38-41</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">239051779</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-YGBF1TMN</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">polinevropatija</subject><subject language_type_id="slv">simptomatsko zdravljenje</subject><title>S kemoterapijo povzročena periferna polinevropatija (CIPN)</title><title>Chemotherapy induced peripheral nevropathy (CIPN)</title></Record>